• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过γ闪烁扫描法测量透明质酸钠在人体角膜前的停留时间。

Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy.

作者信息

Gurny R, Ryser J E, Tabatabay C, Martenet M, Edman P, Camber O

机构信息

Department of Pharmaceutical Technology, University of Geneva, Switzerland.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1990;228(6):510-2. doi: 10.1007/BF00918481.

DOI:10.1007/BF00918481
PMID:2176168
Abstract

The aim of the present study was to quantify in man the distribution and clearance of two aqueous sodium hyaluronate (SH) solutions of 0.125% and 0.250% after the administration of 25 microliters onto the cornea. Isotonic phosphate buffer (PB) was used as a reference instillation. No systemic or local medication was given to the seven 18- to 30-year-old, healthy male volunteers. A detailed evaluation of the anterior segment of the eye, as well as a Schirmer test and a break-up time measurement, yielded results within the normal range. The clearance of 0.125% and 0.250% SH solutions radiolabelled with sodium pertechnetate Tc-99m was measured by gamma scintigraphy and compared with that of a PB solution tagged with the same radiolabel. There was no statistically significant difference between the quantities of 0.125% SH and PB solutions remaining in the precorneal space at 20 min (paired t-test, P = 0.78, n = 7). However, in comparing the 0.250% SH with the PB solution, we observed a statistically significant difference (P = 0.01, n = 7) in the amount remaining in the precorneal space after the same interval. Actually, 53% of the radiolabelled 0.250% SH solution remained on the cornea as compared with 30% for the 0.125% SH solution and 18.3% for the PB solution. These results suggest that an SH solution of 0.250% might have a prolonged residence time on the precorneal surface, and that SH could therefore be used as an additive in various drug-release systems for the eye.

摘要

本研究的目的是在人体中定量检测25微升0.125%和0.250%的两种透明质酸钠(SH)水溶液滴入角膜后的分布和清除情况。使用等渗磷酸盐缓冲液(PB)作为对照滴注液。7名年龄在18至30岁的健康男性志愿者未接受全身或局部用药。对眼前节进行详细评估以及进行泪液分泌试验和泪膜破裂时间测量,结果均在正常范围内。通过γ闪烁显像法测量用高锝酸钠Tc-99m放射性标记的0.125%和0.250% SH溶液的清除情况,并与标记有相同放射性核素的PB溶液进行比较。20分钟时,角膜前间隙中剩余的0.125% SH溶液和PB溶液的量之间无统计学显著差异(配对t检验,P = 0.78,n = 7)。然而,将0.250% SH与PB溶液进行比较时,我们观察到相同时间间隔后角膜前间隙中剩余量存在统计学显著差异(P = 0.01,n = 7)。实际上,放射性标记的0.250% SH溶液有53%留在角膜上,而0.125% SH溶液为30%,PB溶液为18.3%。这些结果表明,0.250%的SH溶液可能在角膜前表面具有延长的停留时间,因此SH可作为眼部各种药物释放系统的添加剂。

相似文献

1
Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy.通过γ闪烁扫描法测量透明质酸钠在人体角膜前的停留时间。
Graefes Arch Clin Exp Ophthalmol. 1990;228(6):510-2. doi: 10.1007/BF00918481.
2
Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin.用作赋形剂的0.25%透明质酸钠可提高局部应用庆大霉素的生物利用度。
Graefes Arch Clin Exp Ophthalmol. 1993 Mar;231(3):157-61. doi: 10.1007/BF00920939.
3
A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy.使用γ闪烁扫描术比较人工泪液制剂在干眼症患者和正常志愿者角膜前的停留情况。
Acta Ophthalmol (Copenh). 1991 Aug;69(4):432-6. doi: 10.1111/j.1755-3768.1991.tb02018.x.
4
Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.通过定量γ闪烁扫描术研究透明质酸钠溶液的角膜前滞留时间。
Eye (Lond). 1990;4 ( Pt 4):594-602. doi: 10.1038/eye.1990.83.
5
Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation.不同玻璃酸钠滴眼液滴眼后泪膜半月板的光学相干断层扫描评估。
Acta Ophthalmol. 2019 Mar;97(2):e162-e169. doi: 10.1111/aos.13887. Epub 2018 Oct 2.
6
Ocular surface residence times of artificial tear solutions.人工泪液制剂在眼表的停留时间。
Cornea. 1992 Jul;11(4):288-93. doi: 10.1097/00003226-199207000-00003.
7
Scintigraphic assessment of an ophthalmic gelling vehicle in man and rabbit.人及兔眼用凝胶制剂的闪烁扫描评估
Curr Eye Res. 1990 May;9(5):415-20. doi: 10.3109/02713689008999606.
8
Viscosity-dependent fluid dynamics of eyedrops on the ocular surface.眼药水在眼表的黏度依赖性流体动力学
Am J Ophthalmol. 1998 Mar;125(3):386-8. doi: 10.1016/s0002-9394(99)80151-2.
9
Scintigraphic studies on the corneal residence of a New Ophthalmic Delivery System (NODS): rate of clearance of a soluble marker in relation to duration of pharmacological action of pilocarpine.新型眼科给药系统(NODS)角膜滞留的闪烁扫描研究:可溶性标记物清除率与毛果芸香碱药理作用持续时间的关系。
Br J Clin Pharmacol. 1992 Jun;33(6):603-9. doi: 10.1111/j.1365-2125.1992.tb04088.x.
10
Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects.健康受试者眼用软膏角膜前滞留情况的评估。
Br J Clin Pharmacol. 1993 Feb;35(2):188-92.

引用本文的文献

1
Why Chain Length of Hyaluronan in Eye Drops Matters.滴眼液中透明质酸的链长为何重要。
Diagnostics (Basel). 2020 Jul 23;10(8):511. doi: 10.3390/diagnostics10080511.
2
Kinetics of Fluorescein in Tear Film After Eye Drop Instillation in Beagle Dogs: Does Size Really Matter?比格犬滴眼后泪膜中荧光素的动力学:大小真的重要吗?
Front Vet Sci. 2019 Dec 19;6:457. doi: 10.3389/fvets.2019.00457. eCollection 2019.
3
Development of Methodologies to Investigate Binding by Sodium Hyaluronate in Eye Drops to Corneal Surfaces.研究滴眼液中透明质酸钠与角膜表面结合的方法的开发

本文引用的文献

1
Peroperative protection of cornea and conjunctiva.术中角膜和结膜的保护。
Acta Ophthalmol (Copenh). 1981 Aug;59(4):587-94. doi: 10.1111/j.1755-3768.1981.tb08346.x.
2
[Use of Healon in defective corneal epithelialization].[透明质酸钠在角膜上皮化缺陷中的应用]
J Fr Ophtalmol. 1984;7(11):755.
3
[Instillation of 0.1% hyaluronic acid in severe keratitis sicca].[0.1%透明质酸在重度干燥性角膜炎中的滴眼治疗]
Open Ophthalmol J. 2018 Jul 31;12:226-240. doi: 10.2174/1874364101812010226. eCollection 2018.
4
Increased concentration of hyaluronan in tears after soaking contact lenses in Biotrue multipurpose solution.将隐形眼镜浸泡在博乐纯多功能护理液中后,泪液中透明质酸浓度增加。
Clin Ophthalmol. 2016 Oct 7;10:1945-1952. doi: 10.2147/OPTH.S115705. eCollection 2016.
5
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery.利用糖胺聚糖/蛋白聚糖作为靶向治疗递送的载体。
Int J Cell Biol. 2015;2015:537560. doi: 10.1155/2015/537560. Epub 2015 Sep 10.
6
Mucoadhesive drug delivery system: An overview.黏膜黏附给药系统:综述。
J Adv Pharm Technol Res. 2010 Oct;1(4):381-7. doi: 10.4103/0110-5558.76436.
7
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.0.18%透明质酸钠治疗中度干眼综合征和浅层角膜炎患者的疗效与安全性。
Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):531-8. doi: 10.1007/s00417-004-1040-6. Epub 2004 Dec 17.
8
Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye.透明质酸对干眼患者角膜上皮屏障功能的有效性
Br J Ophthalmol. 1997 Jul;81(7):533-6. doi: 10.1136/bjo.81.7.533.
9
Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin.用作赋形剂的0.25%透明质酸钠可提高局部应用庆大霉素的生物利用度。
Graefes Arch Clin Exp Ophthalmol. 1993 Mar;231(3):157-61. doi: 10.1007/BF00920939.
J Fr Ophtalmol. 1985;8(6-7):513.
4
Diffusion of some low molecular weight compounds in sodium hyaluronate.一些低分子量化合物在透明质酸钠中的扩散
Acta Pharm Suec. 1985;22(6):315-20.
5
Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits.透明质酸钠对毛果芸香碱诱导家兔减数分裂的影响。
Curr Eye Res. 1987 Jun;6(6):779-84. doi: 10.3109/02713688709034844.
6
The effect of sodium hyaluronate on the corneal epithelium. An ultrastructural study.透明质酸钠对角膜上皮的作用。一项超微结构研究。
Invest Ophthalmol Vis Sci. 1988 Feb;29(2):194-9.
7
Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.透明质酸钠治疗干眼症。一项双盲临床试验。
Acta Ophthalmol (Copenh). 1989 Apr;67(2):181-3. doi: 10.1111/j.1755-3768.1989.tb00750.x.
8
The molecular dynamics of hyaluronates in solution.溶液中透明质酸盐的分子动力学
Biosystems. 1976 Dec;8(3):103-9. doi: 10.1016/0303-2647(76)90013-7.